Ignite Creation Date:
2024-05-06 @ 10:05 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03162874
Status:
COMPLETED
Last Update Posted:
2020-03-17
First Post:
2017-05-19
Brief Title:
Study to Evaluate the Efficacy Safety and Tolerability of PXT002331 Foliglurax in Reducing Motor Complications of Levodopa Therapy in Parkinson Diseases Patients
Sponsor:
Prexton Therapeutics
Organization:
Prexton Therapeutics
Organization Data
Organization:
Prexton Therapeutics
Class:
INDUSTRY
Study ID:
PXT-CL17-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Prexton Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None